Abstract:Background: Deletions in NRXN1 are strongly associated with neurodevelopmental and psychiatric conditions. While exonic deletions are well-studied, intragenic deletions, particularly in intron 5, are less understood and generally consider benign. Recent studies show exonic deletions impact isoform diversity during neurodevelopment, affecting neurogenesis and neuronal function. However, whether intragenic deletions impact isoform expression and neurodevelopment remains underexplored. Methods: We used hiPSCs from typically developing individuals (control) and those with NRXN1 intron 5 deletions to study neurodevelopment. HiPSCs were differentiated towards a cortical fate, with NRXN1 isoform expression, molecular differences, and neuronal morphology examined. Results: We observed distinct NRXN1 isoform expression dynamics during early neurodevelopment, with two expression peaks post-neuronal induction and NRXN1β being most highly expressed. Both NRXN1 deletion and control lines showed similar acquisition of regional and cell fate identity, but significant differences in NRXN1 isoform expression were observed between deletion and control lines, and between deletion lines. RNA sequencing revealed genotype-dependent alterations, particularly in pathways related to synaptic function and neuronal morphology. Consistent with these findings, NRXN1 deletion lines exhibited altered dendrite outgrowth, with variations between deletion lines. Conclusions: Our results indicate a potential role for intron 5 in controlling NRXN1 isoform expression during neurodevelopment. Alterations in gene expression profiles, correlated with morphological changes, suggest a role for NRXN1 isoforms in shaping dendritic morphology. Molecular and cellular differences observed between lines with identical intronic deletions suggest that additional factors, such as genetic background or biological sex, may also play an important role in these phenotypes. Collectively, these findings indicate that NRXN1 intronic deletions are not benign, influencing isoform expression, cellular phenotypes, and neurodevelopment.

Derivation of Ipsc Lines from Two Patients with Autism Spectrum Disorder Carrying NRXN1α Deletion (Nuigi041-A, NUIG041-B; NUIGi045-A) and One Sibling Control (Nuigi042-A, NUIGi042-B)

Derivation of Four Ipsc Lines from a Male ASD Patient Carrying a Deletion in the Middle Coding Region of NRXN1α Gene (Nuigi039-a and NUIGi039-B) and a Male Sibling Control (Nuigi040-a and NUIGi040-B)

Derivation of Two Ipsc Lines from a Sporadic ASD Patient (Nuigi033-A) and a Paternal Control (Nuigi034-A).

NRXN1α+/- is Associated with Increased Excitability in ASD Ipsc-Derived Neurons

Generation of neural cells from DM1 induced pluripotent stem cells as cellular model for the study of central nervous system neuropathogenesis.

Derivation of an induced pluripotent stem cell line (FDCHi014-A) from PBMCs of a seven-year-old patient with a truncating NOVA2 variant (c.625del)

Establishment of Ipsc Line from a Chinese Infant (Xachi012-A) with Jervell and Lange-Nielsen Syndrome Carrying Combined KCNQ1 Frameshift C.431delc(p.i145sfs*92) and Nonsense C.1175g > A (p.w392x) Variants and Two Ipsc Lines from the Parents (Xachi013-A, XACHi014-A).

Derivation of Ipsc Lines from Three Young Healthy Donors of Caucasian Origin (Nuigi035-A; NUIGi036-A; NUIGi037-A).

Generation and characterization of human-derived iPSC lines from two cousins with schizophrenia and bipolar disorder and their unaffected cousin

Imbalance of Excitatory/Inhibitory Neuron Differentiation in Neurodevelopmental Disorders with an NR2F1 Point Mutation.

Imbalance of Excitatory/Inhibitory Neuron Differentiation in Neurodevelopmental Disorders with an NR2F1 Point Mutation

Generation of Ipsc Line (Gibhi001-A) from a Patient with Autism Spectrum Disorder

Bi-allelic NRXN1α deletion in microglia derived from iPSC of an autistic patient increases interleukin-6 production and impairs supporting function on neuronal networking

Impact of intragenic NRXN1 deletions on early cortical development

Generation of a Human Induced Pluripotent Stem Cell Line (Sjtuxhi002-A) from an Individual with Autism Spectrum Disorder Carrying a Heterozygous Mutation in GRIA2.

Generation and characterization of human-derived iPSC lines from one pair of dizygotic twins discordant for schizophrenia.

Generation of an induced pluripotent stem cell line (IPCASi001-A) from an autism spectrum disorder individual without intellectual disability

Deletions of NRXN1 (Neurexin-1) Predispose to a Wide Spectrum of Developmental Disorders.

Generation of three induced pluripotent stem cell lines from a patient with KCNQ2 developmental and epileptic encephalopathy as a result of the pathogenic variant c.881C > T; p.Ala294Val (NUIGi059-A, NUIGi059-B, NUIGi059-C) and 3 healthy controls (NUIGi060-A, NUIGi060-B, NUIGi060-C)

Generation of three induced pluripotent stem cell lines from a patient with KCNQ2 developmental and epileptic encephalopathy as a result of the pathogenic variant c.638C > T; p.Arg213Gln (NUIGi063-A, NUIGi063-B, NUIGi063-C) and 3 healthy controls (NUIGi064-A, NUIGi064-B, NUIGi064-C)

Mutation Analysis of the NRXN1 Gene in a Chinese Autism Cohort